BUZZ-Australia's CSL set for worst week in 2 months on delaying spin-off
Reuters
Oct 31
BUZZ-Australia's CSL set for worst week in 2 months on delaying spin-off
** CSL CSL.AX slips 15.5% to A$179.77 so far this week; set for biggest weekly drop since week ended August 22
** Biotech major no longer targetting spin-off of its vaccine division, Seqirus, in FY26 due to heightened volatility in U.S. influenza vaccine market
** Says demerger will resume when market conditions can support maximisation of shareholder value
** CSL last down 0.1%, takes YTD losses to 36.2%
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.